Correlation Between Vertex Pharmaceuticals and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Viking Therapeutics, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Viking Therapeutics.
Diversification Opportunities for Vertex Pharmaceuticals and Viking Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Vertex and Viking is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and Viking Therapeutics
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 10.02 times less return on investment than Viking Therapeutics. But when comparing it to its historical volatility, Vertex Pharmaceuticals is 7.11 times less risky than Viking Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Viking Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,917 in Viking Therapeutics on September 12, 2024 and sell it today you would earn a total of 2,868 from holding Viking Therapeutics or generate 149.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vertex Pharmaceuticals vs. Viking Therapeutics
Performance |
| Timeline |
| Vertex Pharmaceuticals |
| Viking Therapeutics |
Vertex Pharmaceuticals and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vertex Pharmaceuticals and Viking Therapeutics
The main advantage of trading using opposite Vertex Pharmaceuticals and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |